XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Unaudited Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Balance (in shares) at Dec. 31, 2018   29,576,880      
Balance at Dec. 31, 2018 $ 125,370 $ 30 $ 266,941 $ (3,633) $ (137,968)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 8,961   8,961    
Common stock issued under employee stock plans, net (in shares)   686,357      
Common stock issued under employee stock plans, net (4,642) $ 0 (4,642)    
Realized and unrealized income on derivative instruments 2,935     2,935  
Unrealized gains (losses) on available for sale securities 10     10  
Net loss (22,639)       (22,639)
Ending (in shares) at Mar. 31, 2019   30,263,237      
Balance at Mar. 31, 2019 109,995 $ 30 271,260 (688) (160,607)
Balance (in shares) at Dec. 31, 2018   29,576,880      
Balance at Dec. 31, 2018 125,370 $ 30 266,941 (3,633) (137,968)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Realized and unrealized income on derivative instruments 4,369        
Unrealized gains (losses) on available for sale securities 35        
Net loss (64,114)        
Ending (in shares) at Sep. 30, 2019   30,482,452      
Balance at Sep. 30, 2019 97,770 $ 30 299,051 771 (202,082)
Balance (in shares) at Mar. 31, 2019   30,263,237      
Balance at Mar. 31, 2019 109,995 $ 30 271,260 (688) (160,607)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 14,796   14,796    
Common stock issued under employee stock plans, net (in shares)   63,790      
Common stock issued under employee stock plans, net (1,055) $ 0 (1,055)    
Realized and unrealized income on derivative instruments 912     912  
Unrealized gains (losses) on available for sale securities 34     34  
Net loss (24,488)       (24,488)
Ending (in shares) at Jun. 30, 2019   30,327,027      
Balance at Jun. 30, 2019 100,194 $ 30 285,001 258 (185,095)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 11,022   11,022    
Common stock issued under employee stock plans, net (in shares)   155,425      
Common stock issued under employee stock plans, net 3,028 $ 0 3,028    
Realized and unrealized income on derivative instruments 522     522  
Unrealized gains (losses) on available for sale securities (9)     (9)  
Net loss (16,987)       (16,987)
Ending (in shares) at Sep. 30, 2019   30,482,452      
Balance at Sep. 30, 2019 97,770 $ 30 299,051 771 (202,082)
Balance (in shares) at Dec. 31, 2019   30,583,311      
Balance at Dec. 31, 2019 93,532 $ 31 310,682 (449) (216,732)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 12,883   12,883    
Common stock issued under employee stock plans, net (in shares)   882,959      
Common stock issued under employee stock plans, net 4,316 $ 0 4,316    
Realized and unrealized income on derivative instruments 545     545  
Unrealized gains (losses) on available for sale securities 195     195  
Net loss (31,430)       (31,430)
Ending (in shares) at Mar. 31, 2020   31,466,270      
Balance at Mar. 31, 2020 80,041 $ 31 327,881 291 (248,162)
Balance (in shares) at Dec. 31, 2019   30,583,311      
Balance at Dec. 31, 2019 93,532 $ 31 310,682 (449) (216,732)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Realized and unrealized income on derivative instruments 4,112        
Unrealized gains (losses) on available for sale securities 2        
Net loss (74,978)        
Ending (in shares) at Sep. 30, 2020   31,725,314      
Balance at Sep. 30, 2020 82,920 $ 32 370,933 3,665 (291,710)
Balance (in shares) at Mar. 31, 2020   31,466,270      
Balance at Mar. 31, 2020 80,041 $ 31 327,881 291 (248,162)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 17,623   17,623    
Common stock issued under employee stock plans, net (in shares)   77,249      
Common stock issued under employee stock plans, net 498 $ 1 497    
Realized and unrealized income on derivative instruments 3,367     3,367  
Unrealized gains (losses) on available for sale securities (122)     (122)  
Purchase of capped calls related to Convertible senior notes (29,348)   (29,348)    
Equity component of Convertible senior notes, net 30,794   30,794    
Net loss (24,323)       (24,323)
Ending (in shares) at Jun. 30, 2020   31,543,519      
Balance at Jun. 30, 2020 78,530 $ 32 347,447 3,536 (272,485)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 18,678   18,678    
Common stock issued under employee stock plans, net (in shares)   181,795      
Common stock issued under employee stock plans, net 4,808 $ 0 4,808    
Realized and unrealized income on derivative instruments 200     200  
Unrealized gains (losses) on available for sale securities (71)     (71)  
Net loss (19,225)       (19,225)
Ending (in shares) at Sep. 30, 2020   31,725,314      
Balance at Sep. 30, 2020 $ 82,920 $ 32 $ 370,933 $ 3,665 $ (291,710)